| (Values in U.S. Thousands) | Mar, 2025 | Mar, 2025 | Mar, 2025 | Mar, 2025 | Mar, 2025 |
| Sales | 0 | 0 | 0 | 0 | 0 |
| Sales Growth | unch | unch | unch | unch | unch |
| Net Income | 0 | 0 | 0 | 0 | 0 |
| Net Income Growth | unch | unch | unch | unch | unch |
Anteris Technologies Global Corp (AVR)
5.05 x 10 5.75 x 5
Post-market by (Cboe BZX)
5.18 -0.58 (-10.07%) 03/21/25 [NASDAQ]
5.05 x 10 5.75 x 5
Post-market 5.18 unch (unch) 16:45 ET
for Fri, Mar 21st, 2025
Anteris Technologies Global Corp. is involved in designing, developing and commercializing cutting-edge medical devices to restore healthy heart function. The company's lead product includes DurAVR(R). Anteris Technologies Global Corp. is based in BRISBANE, Australia.
Fiscal Year End Date: 12/31